COA | CORS | CORA Annual Meeting

Program

Chaired by Dr. Glen Richardson (Dalhousie University), the 2024 Annual Meeting program features comprehensive education across all of the orthopaedic subspecialties and showcases the best in research, innovation and critical issues.

Click through each day’s tab, search for speakers or keywords and check back for updates as we add details about all of the exciting sessions taking place from June 12-15

Updates will be made regularly. All programming is subject to changes. All Times listed are in Atlantic Time (AT)

 

Guest Speakers

RI Harris Lecturer

  • Kevin Orrell

Macnab Lecturer

  • Emil Schemitsch

Subspecialty Guest Speakers

AAC

  • Heather Moyse, Canadian Olympic Gold Medalist (Bob Sley) from Prince Edward Island
  • Basil Vrettos, Past President South Africa Orthopaedic Association

CAS

  • Fares Haddad, Editor-in-Chief of Bone & Joint Journal (also participating as CORA Guest Speaker)
  • Kevin Bozic, Past President, American Academy of Orthopaedic Surgeons

COFAS

  • Kevin Martin
    Orthopedic Foot & Ankle Surgeon, Associate Professor
    Ohio State University – Wexner Medical Center
  • James Calder OBE TD MD PhD FRCS (Tr&Orth) FFSEM (UK)
    London, UK
  • Xavier Martin Oliva, Barcelona, Spain
  • Simon Hodkinson, Past President British Orthopaedic Association
  • Bopha Chrea, University of Iowa Hospitals & Clinics

COTS & CSES

  • Emil Schemitsch

CPOS

  • Simon Hadlow, Past President New Zealand Orthopaedic Association
  • Ann Van Heest, President American Orthopaedic Association

CSS

  • Michael Johnson, Past President of the Australian Orthopaedic Association
  • Simon Hadlow, Past President of the New Zealand Orthopaedic Association

WECAN

  • Ann Van Heest, President American Orthopaedic Association
Special Guests

ABC Fellows

  • Anand Segar, New Zealand Orthopaedic Association
  • Maritz Laubscher, South African Orthopaedic Association
  • Sina Babazadeh, Australian Orthopaedic Association
  • Ciara Stevenson, British Orthopaedic Association
  • Jonathan Stevenson, British Orthopaedic Association
  • Xavier Griffen, British Orthopaedic Association
  • Tom Quick, British Orthopaedic Association

Anica Bitenc Fellow

  • Nemanja Jovanovic, Serbian Orthopaedic Trauma Association

Arthroscopy Association of North America

  • Misty Suri
  • Kevin William Farmer

Orthopaedic Trauma Association

  • Lucas Marchand
  • Patrick Kellam
Accreditation Statement

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Orthopaedic Association. You may claim a maximum of 28 hours (credits are automatically calculated).

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Learning Objectives

At the end of this conference, participants will be able to:

  • Review and evaluate the results of clinical advances in the diagnosis and management of common orthopaedic conditions in the areas of traumatology, arthroplasty, foot and ankle, upper extremity, hand and wrist, spine, sports medicine, paediatrics, and oncology.
  • Describe the importance of diversity in orthopaedics.
  • Update and expand their understanding of the advances in basic science research in musculoskeletal health and disease, and apply this understanding to current clinical challenges and the improvement of patient outcomes.
  • Establish strategies that balance both benefit and risk in the care of specific orthopaedic maladies and describe the expected patient outcomes.
  • Discuss innovative ideas with orthopaedic surgery thought leaders.
  • Communicate with colleagues from across the country thereby strengthening professional relationships.
  • Compare and evaluate the latest in orthopaedic equipment and services.
  • Describe the ways in which orthopaedic care is provided in different countries.
2024 Scientific Planning Committee – Conflict of Interest Disclosures
  1. Mailk Ali: No conflict of interest to report.
  2. Aaron Bois:
    1. Membership on advisory boards or speakers’ bureaus: Co-Editor for Elsevier (The Shoulder, textbook)
  3. Anthony Cooper:
    1. Funded grants or clinical trials from: OrthoPediatrics: Unrestricted Research Grant from OrthoPediatrics 2022 – ongoing; POSNA Registry Grant June 1, 2022-May 31, 2025 Canadian Orthopaedic Research Legacy (CORL) Grant 05/2022-05/2024 BC Children’s Hospital Foundation 03/2021-03/2026 CFRI Investigator Grant Award Program (IGAP) 2016 -2026 Canadian Institute of Health Research Grant 2023-2025 War Amps Research Grant 2022-2027
    2. Consultant or employee fees have been received from: Course director for the Canadian Orthoapedic Trauma Course (UBC) which receives sponsorship from OrthoPediatrics and DePuy Synthes. President of the Canadian Paediatric Orthopaedic Society (CPOS).
  4. Gurpreet Dhaliwal: No conflict of interest to report.
  5. James Howard:
    1. Financial payments (including receipt of Honoria) from: Stryker, Smith & Nephew, DePuy, Zimmer, Sonfi, Intellijoint
    2. Funded grants or clinical trials from: DePuy
    3. Other investments/relationships – Consultant or employee fees: Institutional Research Support – DePuy, Zimmer, Smith and Nephew, Microport, Stryker
  6. Kelly Hynes:
    1. Research or institutional support has been received from: AOFAS (American Orthopaedic Foot & Ankle Society)
    2. Consultant or employee fees have been received from: ACUMED
  7. Allison Loewen: No conflict of interest to report.
  8. Matthew Menon:
  9. Christopher Nielsen: No conflict of interest to report.
  10. Glen Richardson:
    1. Research or institutional support has been received from: Stryker, DePuy Synthes
    2. Miscellaneous non-income support, commercially derived honoraria, or other non-research related funding has been received from: Stryker, DePuy Synthes
    3. Stock or stock options held in: Stryker
    4. Consultant or employee fees have been received from: Stryker, DePuy Synthes
  11. Mark Sommerfeldt: No conflict of interest to report.
  12. Allison Tucker: No conflict of interest to report.
  13. David Wilson: No conflict of interest to report.

2024 Program Chair, Glen Richardson